300 related articles for article (PubMed ID: 25243371)
21. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
22. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
[TBL] [Abstract][Full Text] [Related]
23. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis.
Whitby D; Boshoff C
Curr Opin Oncol; 1998 Sep; 10(5):405-12. PubMed ID: 9800110
[TBL] [Abstract][Full Text] [Related]
25. Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis.
Mesri EA; Cavallin LE; Ashlock BM; Leung HJ; Ma Q; Goldschmidt-Clermont PJ
Immunol Res; 2013 Dec; 57(1-3):159-65. PubMed ID: 24203444
[TBL] [Abstract][Full Text] [Related]
26. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
28. Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.
Giffin L; Yan F; Ben Major M; Damania B
J Virol; 2014 Aug; 88(16):9429-41. PubMed ID: 24920810
[TBL] [Abstract][Full Text] [Related]
29. Human herpesvirus 8: is it a tumor virus?
Neipel F; Albrecht JC; Fleckenstein B
Proc Assoc Am Physicians; 1999; 111(6):594-601. PubMed ID: 10591089
[TBL] [Abstract][Full Text] [Related]
30. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Polizzotto MN; Uldrick TS; Wang V; Aleman K; Wyvill KM; Marshall V; Pittaluga S; O'Mahony D; Whitby D; Tosato G; Steinberg SM; Little RF; Yarchoan R
Blood; 2013 Dec; 122(26):4189-98. PubMed ID: 24174627
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
32. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
33. Biology of Kaposi's sarcoma-associated herpesvirus.
Bryan BA; Dyson OF; McCubrey JA; Akula SM
Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
Jary A; Leducq V; Palich R; Gothland A; Descamps D; Joly V; Lambert-Niclot S; Amiel C; Canestri A; Mirand A; Gault E; Vabret A; Valantin MA; Katlama C; Calvez V; Dupin N; Spano JP; Marcelin AG
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29643199
[No Abstract] [Full Text] [Related]
36. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
[TBL] [Abstract][Full Text] [Related]
37. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
38. Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.
Ray A; Marshall V; Uldrick T; Leighty R; Labo N; Wyvill K; Aleman K; Polizzotto MN; Little RF; Yarchoan R; Whitby D
J Infect Dis; 2012 Jun; 205(11):1665-76. PubMed ID: 22448005
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
40. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
